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Background
The estimation of activity of disease in JIA patients is
difficult, and the instruments of an estimation borrowed
from adult rheumatology aren`t much useful for JIA
patients.
Objectives
To assess the correlation between disease activity scores,
using the Juvenile Arthritis Disease Activity Score
(JADAS), Disease activity score 28 (DAS 28) and Physi-
cian`s assessment of disease activity by VAS (PhGlo-
VAS) on a cohort of JIA patients including in the cross-
sectional epidemiological study in Russian Federation
(RUS).
Methods
During 3-moths cross-sectional study in 30 centers of
RUS the data of 1099 consecutive patients were col-
lected. The following key determinants of disease activ-
ity were examined: numbers of tender, swollen joints;
number of active joint and joints with patient assess-
ment of pain and global health scores (VAS); ESR; DAS
28; JADAS-71, PhGloVAS. Relationship between studied
variables was investigated using of a nonparametric
method of Spearman’s correlation analysis.
Results
There were 1099 patients with a mean age of 10.51 ±
4.54 years and the female/male ratio was 1.6. The distri-
butions of JIA patients according to ILAR cacategories
were as follows: systemic 122 (11.1%), oligoarticular 483
(43.94%), RF positive polyarthritis 81 (7.37%), RF nega-
tive polyarthritis 350 (31.84%), enthesitis-related 45
(4.09%), psoriatic 18(1.63%). The median disease
duration was 4.5±3.85 years. The mean value of JADAS-
71 score was 13.04±10.46 (95% CI 0.618), the mean
value of DAS-28 score was 3.13±1.46 (95% CI 0.08) and
mean value PhGloVAS scales was 37±24(95% CI 1.0).
The JADAS-71 correlated with PhGloVAS (r=0.8,
p<0.05) and DAS 28 (r=0.79, p<0.05). Patients have
been distributed on groups according to degree of activ-
ity depending on index DAS 28. In group with remis-
sion (DAS 28<2.6) were 445 patients (40.49%), with low
activity (DAS 28 2.6-3.2) were 208 patients (18.93%),
with moderate activity (DAS 28 3.2-5.1) were 343
patients (31.21%), with high activity (DAS 28 >5.1) were
103 patients (9.37%). In each group the correlation
between JADAS, DAS 28 was defined. The strongest
relationship was determined in patients with high activ-
ity (r=0.79-0.68, p<0.02), and the poor relationship was
in group with low activity (r=0.79-0.21, p<0.0001). In
this group (n= 208) percent of the tendered and swelled
joints which are not considered in an index DAS 28,
were 51,1% and 40,87% respectively. The greatest per-
cent of not considered involved joints was in group of
patients with a sJIA (68.9% tender joints and 71.23%
swelled). Hip, talocrural, and temporal-mandibular joints
often enough are involved at this diagnosis (18.03%,
44.26%, 2.46% respectively in our analysis) and define
functional insufficiency. As a whole, on all cohort of
patients the poor relationship between DAS and JADAS
is at patients with enthesitis-related arthritis ((r=0.79-
0.63, p<0.036).
Conclusion
JADAS and DAS 28 demonstrated strong correlation at
a high degree of activity and poor correlation at a low
degree of activity. Joints of the bottom extremities and
others aren’tc o n s i d e r e di ni n d e xD A S2 8 ,b u tm a k e
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